Alibaba
BABA
Micron Technology
MU
NVIDIA
NVDA
Cisco
CSCO
Netflix
NFLX
US Stock MarketDetailed Quotes
AZN AstraZeneca
- 73.580
- -0.870-1.17%
Close Feb 14 16:00 ET
- 73.580
- 0.0000.00%
Post 20:01 ET
228.18BMarket Cap32.70P/E (TTM)
74.580High73.450Low5.78MVolume74.335Open74.450Pre Close427.85MTurnover0.19%Turnover Ratio32.70P/E (Static)3.10BShares87.67552wk High5.59P/B227.32BFloat Cap62.75052wk Low1.49Dividend TTM3.09BShs Float87.675Historical High2.02%Div YieldTTM1.52%Amplitude5.373Historical Low73.974Avg Price1Lot Size
AstraZeneca Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 18.03%54.07B | 23.84%14.89B | 18.04%13.57B | 13.33%12.94B | 16.55%12.68B | 3.29%45.81B | 7.29%12.02B | 4.64%11.49B | 5.99%11.42B | -4.49%10.88B |
| Operating revenue | 18.03%54.07B | 23.84%14.89B | 18.04%13.57B | 13.33%12.94B | 16.55%12.68B | 3.29%45.81B | 7.29%12.02B | 4.64%11.49B | 5.99%11.42B | -4.49%10.88B |
| Cost of revenue | 23.45%10.21B | 18.07%2.73B | 47.06%3.08B | 11.38%2.18B | 16.43%2.22B | -33.27%8.27B | -20.41%2.31B | -29.75%2.1B | -34.62%1.96B | -45.74%1.91B |
| Gross profit | 16.84%43.87B | 25.22%12.17B | 11.57%10.48B | 13.74%10.76B | 16.57%10.46B | 17.47%37.54B | 16.96%9.72B | 17.46%9.4B | 21.65%9.46B | 13.90%8.97B |
| Operating expense | 11.47%33.86B | 19.43%10.13B | 12.56%8.38B | 14.41%8.01B | 10.20%7.35B | 10.67%30.38B | 32.59%8.48B | 10.19%7.44B | -3.23%7B | -4.79%6.67B |
| Selling and administrative expenses | 3.93%20.53B | 0.67%5.55B | 7.28%5.29B | -1.09%5.06B | 10.42%4.63B | 9.85%19.76B | 44.93%5.52B | 11.95%4.93B | 6.38%5.12B | -15.55%4.19B |
| -Selling and marketing expense | 2.97%555M | -1.38%143M | 12.40%145M | 0.76%132M | 0.75%135M | -97.00%539M | -99.18%145M | 2.38%129M | 1.55%131M | 7.20%134M |
| -General and administrative expense | 3.96%19.98B | 0.73%5.41B | 7.15%5.14B | -1.14%4.93B | 10.74%4.5B | --19.22B | --5.37B | 12.23%4.8B | 6.52%4.99B | -16.14%4.06B |
| Research and development costs | 24.22%13.58B | 52.20%4.68B | 20.55%3.12B | 12.79%3.01B | 6.59%2.78B | 12.02%10.94B | 17.07%3.07B | 5.13%2.58B | 4.75%2.67B | 22.41%2.61B |
| Operating profit | 39.61%10B | 64.99%2.04B | 7.78%2.11B | 11.81%2.75B | 34.97%3.12B | 58.80%7.17B | -35.39%1.23B | 56.95%1.95B | 355.66%2.46B | 162.87%2.31B |
| Net non-operating interest income expense | -0.16%-1.28B | -8.31%-365M | 5.84%-274M | 6.54%-343M | -5.23%-302M | -2.64%-1.28B | -7.67%-337M | 10.19%-291M | -25.26%-367M | 10.03%-287M |
| Non-operating interest income | 33.14%458M | -40.74%64M | 81.19%183M | 56.25%100M | 42.31%111M | 324.69%344M | 248.39%108M | 573.33%101M | 255.56%64M | 358.82%78M |
| Non-operating interest expense | 7.13%1.74B | -3.60%429M | 16.58%457M | 2.78%443M | 13.15%413M | 22.26%1.63B | 29.36%445M | 15.63%392M | 38.59%431M | 8.63%365M |
| Other net income (expense) | ||||||||||
| Special income (charges) | --0 | ---- | ---- | ---- | --0 | 236.16%1.03B | ---- | ---- | ---- | --241M |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | -279.41%-1.03B | ---- | ---- | ---- | ---241M |
| Income before tax | 25.97%8.69B | 85.73%1.67B | 10.65%1.83B | 14.80%2.4B | 23.78%2.8B | 175.85%6.9B | 15.30%897M | 79.18%1.65B | 745.34%2.09B | 309.04%2.26B |
| Income tax | 75.91%1.65B | 367.74%166M | 44.16%395M | 75.00%469M | 35.37%620M | 218.43%938M | 50.00%-62M | 138.06%274M | 337.17%268M | 177.58%458M |
| Net income | 18.12%7.04B | 56.41%1.5B | 3.99%1.43B | 5.93%1.93B | 20.84%2.18B | 81.02%5.96B | 6.32%959M | -16.08%1.38B | 405.56%1.82B | 364.95%1.8B |
| Net income continuous Operations | 18.12%7.04B | 56.41%1.5B | 3.99%1.43B | 5.93%1.93B | 20.84%2.18B | 81.02%5.96B | 6.32%959M | -16.08%1.38B | 405.56%1.82B | 364.95%1.8B |
| Minority interest income | 0.00%6M | 0 | 0.00%4M | -50.00%1M | 0.00%1M | 20.00%6M | -200.00%-1M | 100.00%4M | 2M | -50.00%1M |
| Net income attributable to the parent company | 18.14%7.04B | 56.25%1.5B | 4.00%1.43B | 6.00%1.93B | 20.85%2.18B | 81.11%5.96B | 6.55%960M | -16.22%1.37B | 405.00%1.82B | 367.10%1.8B |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 18.14%7.04B | 56.25%1.5B | 4.00%1.43B | 6.00%1.93B | 20.85%2.18B | 81.11%5.96B | 6.55%960M | -16.22%1.37B | 405.00%1.82B | 367.10%1.8B |
| Basic earnings per share | 18.23%2.27 | 56.45%0.485 | 3.37%0.46 | 5.98%0.62 | 21.55%0.705 | 81.13%1.92 | 6.90%0.31 | -16.04%0.445 | 408.70%0.585 | 364.00%0.58 |
| Diluted earnings per share | 18.11%2.25 | 54.84%0.48 | 3.41%0.455 | 5.98%0.62 | 20.69%0.7 | 80.57%1.905 | 6.90%0.31 | -16.19%0.44 | 408.70%0.585 | 364.00%0.58 |
| Dividend per share | 2.41%1.485 | 0 | 7.53%0.5 | 0 | 0.00%0.985 | 0.00%1.45 | 0 | 0.00%0.465 | 0 | 0.00%0.985 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
